Ciprofloxacin carrier systems based on hectorite/halloysite hybrid hydrogels for potential wound healing applications
Source abstract
Abstract
The design of multifunctional nanomaterials which can help the healing processes of skin, preventing the bacterial infections, is crucial for the development of suitable therapy for the treatment of chronic lesions. The use of clay minerals in wound healing applications is well documented since the prehistoric period and offers several advantages due to their intrinsic properties. Herein, we report the development of ciprofloxacin carrier systems based on hectorite/halloysite (Ht/Hal) hybrid hydrogels for potential wound healing applications. To achieve this objective firstly the ciprofloxacin molecules were loaded onto Hal by a supramolecular and covalent approach. The so obtained fillers were thoroughly investigated by several techniques and at molecular level by means of quantum mechanics calculations along with empirical interatomic potentials. Afterwards the modified Hal were used as filler for Ht hydrogels. The introduction of modified Hal, in hectorite hydrogel, helps the gel formation with an improvement of the rheological properties. The in vitro kinetic release from both the fillers and from the hybrid hydrogels was studied both at skin's pH (5.4) and under neutral conditions (pH 7.4); in addition, the factors controlling the ciprofloxacin release process were determined and discussed. Finally, the in vitro biocompatibility of the Hal fillers was evaluated by means of cytotoxic assays and laser scanning confocal microscopy on normal human dermal fibroblasts.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Therapeutic Uses of Natural Elements · Clay minerals and soil interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Halloysite-Doped Zinc Oxide for Enhanced Sunscreening Performance10.1021/acsanm.9b01482 ↗
2. Site-specific halloysite functionalization by polydopamine: A new synthetic route for potential near infrared-activated delivery system10.1016/j.jcis.2021.08.155 ↗
3. Ecotoxicity of halloysite nanotube–supported palladium nanoparticles in Raphanus sativus L10.1002/etc.3412 ↗
4. Molecular and crystal structure of praziquantel. Spectroscopic properties and crystal polymorphism10.1016/j.ejps.2016.04.023 ↗
5. Molecular modeling and infrared and Raman spectroscopy of the crystal structure of the chiral antiparasitic drug Praziquantel10.1007/s00894-017-3266-3 ↗
6. Molecular Modeling of Adsorption of 5-Aminosalicylic Acid in the Halloysite Nanotube10.3390/min8020061 ↗
7. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives10.1016/j.ijpharm.2008.12.026 ↗
8. Thermodynamics of Proton Binding of Halloysite Nanotubes10.1021/acs.jpcc.6b01127 ↗
9. Ciprofloxacin10.2165/00003495-198835040-00003 ↗
10. Assessment of halloysite nanotubes as vehicles of isoniazid10.1016/j.colsurfb.2017.09.036 ↗
11. Montmorillonite enhanced ciprofloxacin transport in saturated porous media with sorbed ciprofloxacin showing antibiotic activity10.1016/j.jconhyd.2014.11.010 ↗
12. Clay: New Opportunities for Tissue Regeneration and Biomaterial Design10.1002/adma.201301034 ↗
13. Toxicity of halloysite clay nanotubes in vivo: a Caenorhabditis elegans study
14. Assessment of Hectorite/Spring Water Hydrogels as Wound Healing Products
15. Fluorescent gold nanoclusters stabilized on halloysite nanotubes: in vitro study on cytotoxicity10.1016/j.clay.2021.106106 ↗
16. Structural, Electronic, and Mechanical Properties of Single-Walled Halloysite Nanotube Models10.1021/jp100902e ↗
17. Rational design and latest advances of polysaccharide-based hydrogels for wound healing10.1039/D0BM00055H ↗
18. Biodegradable gelatin–ciprofloxacin–montmorillonite composite hydrogels for controlled drug release and wound dressing application10.1016/j.colsurfb.2014.06.051 ↗
19. Incorporation and release of a model drug, ciprofloxacin, from non-modified SBA-15 molecular sieves with different pore sizes10.1016/j.micromeso.2019.109903 ↗
20. Evaluation of toxicity of nanoclays and graphene oxide in vivo: a Paramecium caudatum study
21. Mussel-inspired, antibacterial, conductive, antioxidant, injectable composite hydrogel wound dressing to promote the regeneration of infected skin10.1016/j.jcis.2019.08.083 ↗
22. Halloysite nanotube functionalized with La-Ca bimetallic oxides as novel transesterification catalyst for biodiesel production with molecular simulation
23. Recent advance in research on halloysite nanotubes-polymer nanocomposite10.1016/j.progpolymsci.2014.04.004 ↗
24. Clay nanotube encapsulation for functional biocomposites10.1016/j.cis.2013.10.006 ↗
25. Ecocompatible Halloysite/Cucurbit[8]uril Hybrid as Efficient Nanosponge for Pollutants Removal10.1002/slct.201600322 ↗
26. Halloysite nanotubes for efficient loading, stabilization and controlled release of insulin10.1016/j.jcis.2018.04.025 ↗
27. Photoluminescent hybrid nanomaterials from modified halloysite nanotubes10.1039/C8TC01424H ↗
28. Halloysite nanotubes-carbon dots hybrids multifunctional nanocarrier with positive cell target ability as a potential non-viral vector for oral gene therapy10.1016/j.jcis.2019.05.062 ↗
29. Multifunctional Carrier Based on Halloysite/Laponite Hybrid Hydrogel for Kartogenin Delivery10.1021/acsmedchemlett.8b00465 ↗
30. One-pot synthesis of ZnO nanoparticles supported on halloysite nanotubes for catalytic applications
31. Past, present and future perspectives on halloysite clay minerals10.3390/molecules25204863 ↗
32. Chemical and biological evaluation of cross-linked halloysite-curcumin derivatives
33. Pyrazole[3,4-d]pyrimidine derivatives loaded into halloysite as potential CDK inhibitors
34. Synthesis and characterization of nanomaterial based on halloysite and hectorite clay minerals covalently bridged10.3390/nano11020506 ↗
35. Clay nanotube–biopolymer composite scaffolds for tissue engineering10.1039/C6NR00641H ↗
36. Emerging role of nanoclays in cancer research, diagnosis, and therapy10.1016/j.ccr.2021.213956 ↗
37. Molecular dynamics of the halloysite nanotubes10.1039/C7CP06575B ↗
38. Boosting the properties of a fluorescent dye by encapsulation into halloysite nanotubes10.1016/j.dyepig.2020.109094 ↗
39. Cytocompatibility and cellular uptake of alkylsilane-modified hydrophobic halloysite nanotubes10.1016/j.clay.2019.105371 ↗
40. Comparative cytotoxicity of kaolinite, halloysite, multiwalled carbon nanotubes and graphene oxide10.1016/j.clay.2021.106041 ↗
41. Enhanced removal of diclofenac by an organohalloysite intercalated via a novel route: Performance and mechanism
42. Sandri, G., Faccendini, A., Longo, M., Ruggeri, M., Rossi, S., Bonferoni, M.C., Miele, D., Prina-Mello, A., Aguzzi, C., Viseras, C., Ferrari, F., 2020. Halloysite- and Montmorillonite-Loaded Scaffolds as Enhancers of Chronic Wound Healing. Pharmaceutics 12, 179.10.3390/pharmaceutics12020179 ↗
43. Biomedical potential of clay nanotube formulations and their toxicity assessment10.1080/17425247.2019.1665020 ↗
44. Montmorillonite-based polyacrylamide hydrogel rings for controlled vaginal drug delivery10.1016/j.msec.2019.110609 ↗
45. Antimicrobial gelatin-based elastomer nanocomposite membrane loaded with ciprofloxacin and polymyxin B sulfate in halloysite nanotubes for wound dressing10.1016/j.msec.2018.02.025 ↗
46. Adsorption of tamoxifen on montmorillonite surface10.1016/j.micromeso.2020.110012 ↗
47. Fluorescence and Cytotoxicity of Cadmium Sulfide Quantum Dots Stabilized on Clay Nanotubes10.3390/nano8060391 ↗
48. Ru/CdS Quantum Dots Templated on Clay Nanotubes as Visible-Light-Active Photocatalysts: Optimization of S/Cd Ratio and Ru Content10.1002/chem.202002192 ↗
49. Rheology modification in mixed shape colloidal dispersions. Part I: pure components10.1039/b704742h ↗
50. Rheology modification in mixed shape colloidal dispersions. Part II: mixtures10.1039/B713144E ↗
51. Halloysite Clay Nanotubes for Enzyme Immobilization10.1021/acs.biomac.5b01542 ↗
52. Crystal structure of ciprofloxacin hexahydrate and its characterization10.1016/S0378-5173(97)04913-2 ↗
53. Adsorption of ciprofloxacin on 2:1 dioctahedral clay minerals10.1016/j.clay.2011.06.014 ↗
54. What Makes a Natural Clay Antibacterial?10.1021/es1040688 ↗
55. Desorption of ciprofloxacin from clay mineral surfaces10.1016/j.watres.2012.10.010 ↗